This page describes the surveillance of COVID-19 in the Netherlands during the respiratory season 2023/2024.

This page describes the surveillance of COVID-19 in the Netherlands during the respiratory season 2023/2024. Since most respiratory infections occur mainly in winter, the data are presented for a respiratory season or a respiratory year. A respiratory season runs from week 40 of one year to week 20 of the following year. A respiratory year runs from week 40 of one year to week 39 of the following year. In this retrospect, the data from the respiratory year 2023/2024 is limited to the respiratory season. For more details on the various surveillance sources, see the background and method document on respiratory surveillance for 2023/2024.

Peak at the end of 2023

In the summer of 2023, during the respiratory year 2022/2023, there was little circulation of the SARS-CoV-2 virus in the Netherlands. From July 2023 (weeks 26-29), virus circulation gradually increased.

In the respiratory season 2023/2024, wastewater surveillance indicated that after the gradual increase since July 2023 (from week 26), virus circulation increased stronger since the end of October 2023 (from week 43). The amount of SARS-CoV-2 virus particles in wastewater peaked in weeks 50-51 (December 2023). The percentage of Infectieradar participants reporting a positive self-test showed a similar pattern, with a gradual increase from week 29 and a peak in week 50 2023. The number of COVID-19-related hospital admissions, after a gradual increase since week 29, stabilized around an average of 100 admissions per day from week 43 to 48 in 2023 and then began to rise again to a peak of an average of 165 admissions per day in week 51. By the end of January 2024, the circulation of SARS-CoV-2 had returned to the level before the surge in November/December (weeks 46-52, 2023).

Subvariants of the coronavirus SARS-CoV-2

In the national SARS-CoV-2 pathogen surveillance, it was observed that from June to October 2023, various omicron (sub)variants of SARS-CoV-2 circulated alongside each other. From week 37 in 2023, the SARS-CoV-2-subvariant JN.1() began to appear in the national strain surveillance and grew to become the driver of the epidemic surge in the last months of 2023. This subvariant was responsible for more than 90% of SARS-CoV-2 cases by early 2024. It was the first omicron subvariant since BA.5 (in the summer of 2022) to reach such a high share. JN.1 has a growth advantage over previously circulating variants and possesses some antigenic advantage that evades prior immunity, but it does not seem to cause more severe illness than earlier omicron variants.

The number of measured SARS-CoV-2 virus particles in wastewater (4,343 particles x100 billion per 100,000 inhabitants) was the highest reported so far in week 51 of 2023. The growth advantage of the omicron subvariant JN.1, combined with possibly higher shedding in feces, could explain this high peak. Similar to the wastewater, the observed peak in Infectieradar participants with a positive test was higher than the previous surge in February-March 2023, but it was not as high as the surge in March 2022, after the omicron variants became dominant. The peak in hospital admissions in week 51 of 2023 (165 admissions) was comparable to the peak of 173 admissions in week 10 of 2023 during the previous surge in February/March 2023. SARS-CoV-2 does not yet have a stable seasonal pattern, and surges can also occur outside the respiratory season.

COVID-19 vaccination

The COVID-19 vaccination programme for people aged 60 and over and specific risk groups started in October 2023 (week 40). The timing of the vaccination programme may have contributed to the stabilization of the number of hospital admissions in October and November 2023, despite the increased virus circulation.

Figure 3. Number of weekly reported positive test results for SARS-CoV-2 in the virological laboratory

Skip chart Figure 3. Number of weekly reported positive test results for SARS-CoV-2 in the virological laboratory surveillance for the respiratory years 2019/2020 to 2022/2023 and for the respiratory season (up to week 20) 2023/2024. and go to datatable

Note: Due to the large number of detections in 2021/2022 (in yellow), these numbers are displayed on the right side of the figure. The testing policy for SARS-CoV-2 has changed frequently during and after the pandemic. As a result, the absolute numbers across different years are not comparable.
Note: This data is owned by the laboratories participating in virological laboratory surveillance, represented by the board of the Dutch Working Group for Clinical Virology (NWKV). The database management is handled by RIVM. Further use of this data is not allowed without permission. Permission to use this data can be requested by contacting  virweekstaten@rivm.nl.

More about surveillance of respiratory infections

More about surveillance of respiratory infections